Statement on Intractable Pain Treatment Acts. The American Alliance of Cancer Pain Initiatives. J Pain Palliat Care Pharmacother, 2004; 18,2:93–98.
2.
JostL, RoilaF. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol, 2010; 21,suppl 5:257–260.
3.
FainsingerRL, NekolaichukCL. A “TNM” classification system for cancer pain: The Edmonton Classification System for Cancer Pain (ECS–CP)Support Care Cancer, 2008; 16,6:547–555.
4.
FainsingerRL, NekolaichukC, LawlorP, HagenN, BercovitchM, FischM, GallowayL, KayeG, LandmanW, SpruytO, ZhukovskyD, BrueraE, HansonJ. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer, 2010; 46,16:2896–2904.
5.
FainsingerRL, NekolaichukCL, LawlorPG, NeumannCM, HansonJ, ViganoA. A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage, 2005; 29,3:224–237.
BennettM. The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain, 2001; 92,1–2:147–157.
8.
HoangBX, TranDMet al. Dimethyl sulfoxide and sodium bicarbonate in the treatment of refractory cancer pain. J Pain Palliat Care Pharmacother, 2011; 25,1:19–24.
